KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Invested Capital: 2009-2025

Historic Return on Invested Capital for Teva Pharmaceutical Industries (TEVA) over the last 6 years, with Sep 2025 value amounting to 0.18%.

  • Teva Pharmaceutical Industries' Return on Invested Capital was N/A to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year change of. This contributed to the annual value of 0.04% for FY2023, which is 19.00% up from last year.
  • According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Return on Invested Capital is 0.18%, which was up 738.87% from 0.02% recorded in Q1 2024.
  • Teva Pharmaceutical Industries' Return on Invested Capital's 5-year high stood at 0.18% during Q3 2025, with a 5-year trough of -0.24% in Q1 2021.
  • For the 3-year period, Teva Pharmaceutical Industries' Return on Invested Capital averaged around 0.04%, with its median value being 0.03% (2024).
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Return on Invested Capital skyrocketed by 36bps in 2021, and later declined by 24bps in 2022.
  • Over the past 5 years, Teva Pharmaceutical Industries' Return on Invested Capital (Quarterly) stood at 0.09% in 2021, then declined by 24bps to -0.15% in 2022, then grew by 20bps to 0.05% in 2023, then rose by 13bps to 0.02% in 2024, then reached 0.18% in 2025.
  • Its last three reported values are 0.18% in Q3 2025, 0.02% for Q1 2024, and 0.05% during Q4 2023.